Anteris Technologies Global Corp.

Anteris Technologies Global Corp. (AVR) priced its initial public offering on Dec 13, 2024 at $6.00 per share, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $215.6M. TD Cowen was lead-left underwriter, joined by Barclays, Cantor and Lake Street. Jones Day advised the company and Covington & Burling advised the underwriters.

Anteris Technologies Global Corp. is a development-stage structural heart company creating medical devices for patients with aortic stenosis. Its lead product, the DurAVR transcatheter heart valve system, is a single-piece biomimetic valve made with proprietary ADAPT tissue.

Status

IPO

Ticker

AVR

Exchange

Nasdaq Global Market

Priced

Dec 13, 2024

IPO price

$6.00

Market cap at IPO price

$215.6M

First filed

Nov 22, 2024

Underwriters

TD Cowen, Barclays, Cantor and Lake Street

Company counsel

Jones Day

Underwriters' counsel

Covington & Burling

Sector

Healthcare

Country / state

MN

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.